Lyell Immunopharma, Inc. (LYEL)

Nasdaq · Pharmaceutical Preparations · Inc. DE

What they're doing

Not enough recent activity to summarise.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing director or officer change
  2. Insider buying cluster
    4 insiders bought $50.0M within 14 days
  3. Insider purchase
    ARCH Venture Partners IX Overage, L.P. (ten_percent_owner) bought $12.5M of stock
  4. Insider purchase
    BERNS PAUL L (ten_percent_owner) bought $12.5M of stock
  5. Material 8-K filing
    Filed 8-K disclosing material agreement
  6. Material 8-K filing
    Filed 8-K disclosing director or officer change

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-09-10Shook DavidofficerS50012.7$6,350
2026-08-21Seely LynndirectorS9,58915.54$149,013
2026-08-21Hill Stephen J.officerS98915.54$15,369
2026-08-21Lee Gary K.officerS1,45715.54$22,642
2026-08-10Bulis Veronica SanchezofficerS62114.34$8,905
2026-08-10Lee Gary K.officerS13114.34$1,879
2026-08-10Hill Stephen J.officerS8914.34$1,276
2026-08-10Seely LynndirectorS39014.34$5,593
2026-07-27Innovative Cellular Therapeutics Holdings Ltdten percent ownerJ44,0000$0
2026-07-27Innovative Cellular Therapeutics Holdings Ltdten percent ownerJ38,5000$0
2026-07-17Innovative Cellular Therapeutics Holdings Ltdten percent ownerS1013.7$137
2026-07-16Innovative Cellular Therapeutics Holdings Ltdten percent ownerS1013.73$137
2026-06-29Innovative Cellular Therapeutics Holdings Ltdten percent ownerJ76,0000$0
2026-06-15Innovative Cellular Therapeutics Holdings Ltdten percent ownerJ66,5000$0
2026-06-15Innovative Cellular Therapeutics Holdings Ltdten percent ownerJ66,5000$0
2026-06-10Shook DavidofficerS1,97712.64$24,989
2026-06-10Shook DavidofficerS1,97712.64$24,989
2026-05-11Seely LynndirectorS38818.91$7,337
2026-05-11Lee Gary K.officerS13018.92$2,460
2026-05-11Hill Stephen J.officerS8918.92$1,684
2026-05-11Bulis Veronica SanchezofficerS21718.91$4,103
2026-05-11Seely LynndirectorS38818.91$7,337
2026-05-11Lee Gary K.officerS13018.92$2,460
2026-05-11Hill Stephen J.officerS8918.92$1,684
2026-05-11Bulis Veronica SanchezofficerS21718.91$4,103
2026-03-06ARCH Venture Partners IX Overage, L.P.ten percent ownerP488,09025.61$12,499,985
2026-03-06BERNS PAUL Lten percent ownerP488,09025.61$12,499,985
2026-03-06ARCH Venture Partners IX, LLC; ARCH Venture Partners IX, L.P.; ARCH Venture Partners IX Overage, L.P.; ARCH Venture Fund IX, L.P.; ARCH Venture Fund IX Overage, L.P.ten percent ownerP488,09025.61$12,499,985
2026-03-06ARCH Venture Fund XIII, L.P.; ARCH Venture Partners XIII, L.P.; ARCH Venture Partners XIII, LLC; CRANDELL KEITH; NELSEN ROBERT; Burow Kristina; GILLIS STEVEN; BERNS PAUL L; BYBEE CLINTONten percent ownerP488,09025.61$12,499,985
2026-02-11Seely LynndirectorS7,45523.39$174,372
2026-02-11Hill Stephen J.officerS1,23623.39$28,910
2026-02-11Lee Gary K.officerS1,67123.39$39,085
2026-02-11Seely LynndirectorS7,45523.39$174,372
2026-02-11Hill Stephen J.officerS1,23623.39$28,910
2026-02-11Lee Gary K.officerS1,67123.39$39,085
2026-02-10Hill Stephen J.officerS10923.12$2,520
2026-02-10Lee Gary K.officerS14723.12$3,399
2026-02-10Seely LynndirectorS43823.12$10,127
2026-02-10Bulis Veronica SanchezofficerS25423.12$5,872
2026-02-10Bulis Veronica SanchezofficerA8,7500$0
2026-02-10Hill Stephen J.officerS10923.12$2,520
2026-02-10Lee Gary K.officerS14723.12$3,399
2026-02-10Seely LynndirectorS43823.12$10,127
2026-02-10Bulis Veronica SanchezofficerA8,7500$0
2026-02-10Bulis Veronica SanchezofficerS25423.12$5,872
2026-02-09Hill Stephen J.officerA4,0000$0
2026-02-09Lee Gary K.officerA4,0000$0
2026-02-09Seely LynndirectorA20,0000$0
2026-02-09Hill Stephen J.officerA4,0000$0
2026-02-09Lee Gary K.officerA4,0000$0

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings

  • 2026-09-10 8-K
  • 2026-09-10 3
  • 2026-09-10 4
  • 2026-09-10 4
  • 2026-08-25 4
  • 2026-08-25 4
  • 2026-08-25 4
  • 2026-08-14 SCHEDULE 13G/A
  • 2026-08-11 4
  • 2026-08-11 4
  • 2026-08-11 4
  • 2026-08-11 4
  • 2026-08-06 10-Q
  • 2026-08-06 8-K
  • 2026-07-27 4
  • 2026-07-27 4
  • 2026-07-21 EFFECT
  • 2026-07-20 4
  • 2026-07-17 4
  • 2026-07-17 CORRESP